<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35224306</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-199X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Bioactive materials</Title>
          <ISOAbbreviation>Bioact Mater</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The protein corona modulates the inflammation inhibition by cationic nanoparticles <i>via</i> cell-free DNA scavenging.</ArticleTitle>
        <Pagination>
          <StartPage>249</StartPage>
          <EndPage>259</EndPage>
          <MedlinePgn>249-259</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bioactmat.2021.10.044</ELocationID>
        <Abstract>
          <AbstractText>A central paradigm in nanomedicine is that when synthetic nanoparticles (NPs) enter the body, they are immediately cloaked by a corona of macromolecules (mostly proteins) that mediates the role of the physico-chemical properties in the NP biological functions (the "coronation paradigm"). In this work, we focused on the assessment of the "coronation paradigm" for cationic NPs (cNPs) used as rheumatoid arthritis (RA) drugs due to their ability to scavenge cell-free DNA (cfDNA). We fabricated series of cNPs uniformly coated with single or di-hydroxyl groups and different types of amino groups and showed that hydroxylated nanoparticles displayed a prolonged retention in inflamed joints and greater anti-inflammatory effect in collagen-induced arthritis (CIA) rats than the non-hydroxylated analogues. Especially, the cNPs with secondary amines and a di-hydroxyl shell showed the best performance among the tested cNPs. Proteomic analysis showed that the cNPs with a di-hydroxyl shell adsorbed less opsonin proteins than the cNPs carrying mono hydroxyl groups and non-hydroxylated ones, which may provide a mechanistic explanation for the different biodistribution profiles of cNPs. Thus, this study suggests that the protein corona mediates the effects of the surface chemistry on the fate and functions of cNPs as anti-RA drugs.</AbstractText>
          <CopyrightInformation>© 2021 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Xingliang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-sen University, Guangzhou, 510275, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liang</LastName>
            <ForeName>Huiyi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-sen University, Guangzhou, 510275, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Yanzi</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-sen University, Guangzhou, 510275, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Jingjiao</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-sen University, Guangzhou, 510275, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bottini</LastName>
            <ForeName>Massimo</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Experimental Medicine, University of Rome Tor Vergata, Rome, 00133, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Lixin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-sen University, Guangzhou, 510275, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Yongming</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Sun Yat-sen University, Guangzhou, 510275, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Bioact Mater</MedlineTA>
        <NlmUniqueID>101685294</NlmUniqueID>
        <ISSNLinking>2452-199X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cationic nanoparticles</Keyword>
        <Keyword MajorTopicYN="N">Cell-free DNA</Keyword>
        <Keyword MajorTopicYN="N">Inflammation inhibition</Keyword>
        <Keyword MajorTopicYN="N">Protein corona</Keyword>
        <Keyword MajorTopicYN="N">Rheumatoid arthritis</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>5</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35224306</ArticleId>
        <ArticleId IdType="pmc">PMC8843952</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bioactmat.2021.10.044</ArticleId>
        <ArticleId IdType="pii">S2452-199X(21)00508-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jeong M., Park J.H. Nanomedicine for the treatment of rheumatoid arthritis. Mol. Pharm. 2021;18:539–549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32502346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira I.M., Gonçalves C., Reis R.L., Oliveira J.M. Engineering nanoparticles for targeting rheumatoid arthritis: past, present, and future trends. Nano Res. 2018;11:4489–4506.</Citation>
        </Reference>
        <Reference>
          <Citation>Smolen J.S., Aletaha D., McInnes I.B. Rheumatoid arthritis. Lancet. 2016;388:2023–2038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27156434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burmester G.R., Pope J.E. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389:2338–2348.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28612748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dolati S., Sadreddini S., Rostamzadeh D., Ahmadi M., Jadidi-Niaragh F., Yousefi M. Utilization of nanoparticle technology in rheumatoid arthritis treatment, Biomed. Pharma. 2016;80:30–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27133037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q., Sun X. Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomater. Sci. 2017;5:1407–1420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28631779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madav Y., Barve K., Prabhakar B. Current trends in theranostics for rheumatoid arthritis. Eur. J. Pharmaceut. Sci. 2020;145:105240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31987984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duvvuri B., Lood C. Cell-free DNA as a biomarker in autoimmune rheumatic diseases. Front. Immunol. 2019;10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6433826</ArticleId>
            <ArticleId IdType="pubmed">30941136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhong X.Y., von Mühlenen I., Li Y., Kang A., Gupta A.K., Tyndall A., Holzgreve W., Hahn S., Hasler P. Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis. Clin. Chem. 2007;53:1609–1614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17712000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pisetsky D.S., Gauley J., Ullal A.J. Microparticles as a source of extracellular DNA. Immunol. Res. 2011;49:227–234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3724471</ArticleId>
            <ArticleId IdType="pubmed">21132466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orozco A.F., Jorgez C.J., Horne C., Marquez-Do D.A., Chapman M.R., Rodgers J.R., Bischoff F.Z., Lewis D.E. Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia. Am. J. Pathol. 2008;173:1595–1608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2626372</ArticleId>
            <ArticleId IdType="pubmed">18974299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hashimoto T., Yoshida K., Hashimoto N., Nakai A., Kaneshiro K., Suzuki K., Kawasaki Y., Shibanuma N., Hashiramoto A. Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis. Int. J. Rheum. Dis. 2017;20:722–730.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27943573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong C., Liu Y., Sun C., Liang H., Dai L., Shen J., Wei S., Guo S., Leong K.W., Chen Y., Wei L., Liu L. Identification of specific joint-inflammatogenic cell-free DNA molecules from synovial fluids of patients with rheumatoid arthritis. Front. Immunol. 2020;11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7198838</ArticleId>
            <ArticleId IdType="pubmed">32411129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J., Sohn J.W., Zhang Y., Leong K.W., Pisetsky D., Sullenger B.A. Nucleic acid-binding polymers as anti-inflammatory agents. Proc. Natl. Acad. Sci. Unit. States Am. 2011;108:14055–14060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3161575</ArticleId>
            <ArticleId IdType="pubmed">21844380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yanai H., Ban T., Wang Z., Choi M.K., Kawamura T., Negishi H., Nakasato M., Lu Y., Hangai S., Koshiba R., Savitsky D., Ronfani L., Akira S., Bianchi M.E., Honda K., Tamura T., Kodama T., Taniguchi T. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 2009;462:99–103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19890330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.H., Homey B., Cao W., Wang Y.H., Su B., Nestle F.O., Zal T., Mellman I., Schröder J.M., Liu Y.J., Gilliet M. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007;449:564–569.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17873860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Urbonaviciute V., Fürnrohr B.G., Meister S., Munoz L., Heyder P., De Marchis F., Bianchi M.E., Kirschning C., Wagner H., Manfredi A.A., Kalden J.R., Schett G., Rovere-Querini P., Herrmann M., Voll R.E. Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 2008;205:3007–3018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2605236</ArticleId>
            <ArticleId IdType="pubmed">19064698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L.L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M.K., Fitzgerald K.A., Latz E., Kiener P.A., Coyle A.J. Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 2007;8:487–496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17417641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunaeva M., Buddingh’ B.C., Toes R.E.M., Luime J.J., Lubberts E., Pruijn G.J.M. Decreased serum cell-free DNA levels in rheumatoid arthritis. Autoimmun. Highlights. 2015;6:23–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4536238</ArticleId>
            <ArticleId IdType="pubmed">26113482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang P., Lo Y.M.D. The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics. Trends Genet. 2016;32:360–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27129983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lau C.M., Broughton C., Tabor A.S., Akira S., Flavell R.A., Mamula M.J., Christensen S.R., Shlomchik M.J., Viglianti G.A., Rifkin I.R., Marshak-Rothstein A. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 2005;202:1171–1177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2213226</ArticleId>
            <ArticleId IdType="pubmed">16260486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holl E.K., Shumansky K.L., Borst L.B., Burnette A.D., Sample C.J., Ramsburg E.A., Sullenger B.A. Scavenging nucleic acid debris to combat autoimmunity and infectious disease. Proc. Natl. Acad. Sci. Unit. States Am. 2016;113:9728–9733.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5024580</ArticleId>
            <ArticleId IdType="pubmed">27528673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dawulieti J., Sun M., Zhao Y., Shao D., Yan H., Lao Y.H., Hu H., Cui L., Lv X., Liu F., Chi C.W., Zhang Y., Li M., Zhang M., Tian H., Chen X., Leong K.W., Chen L. Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers. Sci. Adv. 2020;6:7148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7259927</ArticleId>
            <ArticleId IdType="pubmed">32523983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang H., Yan Y., Wu J., Ge X., Wei L., Liu L., Chen Y. Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys. Sci. Adv. 2020;6:5274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7457336</ArticleId>
            <ArticleId IdType="pubmed">32923608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang H., Peng B., Dong C., Liu L., Mao J., Wei S., Wang X., Xu H., Shen J., Mao H.Q., Gao X., Leong K.W., Chen Y. Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation. Nat. Commun. 2018;9:4291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6191420</ArticleId>
            <ArticleId IdType="pubmed">30327464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng B., Liang H., Li Y., Dong C., Shen J., Mao H.-Q., Leong K., Chen Y., Liu L. Tuned cationic dendronized polymer as a molecular scavenger for rheumatoid arthritis treatment. Angew. Chem. 2019;131</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30724436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J., Liang H., Li Y., Shi Y., Bottini M., Chen Y., Liu L. Cationic block copolymer nanoparticles with tunable DNA affinity for treating rheumatoid arthritis. Adv. Funct. Mater. 2020;30:2000391.</Citation>
        </Reference>
        <Reference>
          <Citation>Nguyen V.H., Lee B.-J. Protein corona: a new approach for nanomedicine design. Int. J. Nanomed. 2017;12:3137–3151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5402904</ArticleId>
            <ArticleId IdType="pubmed">28458536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tenzer S., Docter D., Kuharev J., Musyanovych A., Fetz V., Hecht R., Schlenk F., Fischer D., Kiouptsi K., Reinhardt C., Landfester K., Schild H., Maskos M., Knauer S.K., Stauber R.H. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 2013;8:772–781.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24056901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zou Y., Ito S., Yoshino F., Suzuki Y., Zhao L., Komatsu N. Polyglycerol grafting shields nanoparticles from protein corona formation to avoid macrophage uptake. ACS Nano. 2020;14:7216–7226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32379425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q.F., Yi W.J., Wang B., Zhang J., Ren L., Chen Q.M., Guo L., Yu X.Q. Linear polycations by ring-opening polymerization as non-viral gene delivery vectors. Biomaterials. 2013;34:5391–5401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23582685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li R.Q., Wu Y., Zhi Y., Yang X., Li Y., Xu F.J., Du J. PGMA-based star-like polycations with plentiful hydroxyl groups act as highly efficient miRNA delivery nanovectors for effective applications in heart diseases. Adv. Mater. 2016;28:7204–7212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27297033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhi Y., Xu C., Sui D., Du J., Xu F.J., Li Y. Effective delivery of hypertrophic miRNA inhibitor by cholesterol-containing nanocarriers for preventing pressure overload induced cardiac hypertrophy. Adv. Sci. 2019;6:1900023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6548964</ArticleId>
            <ArticleId IdType="pubmed">31179215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saha K., Rahimi M., Yazdani M., Kim S.T., Moyano D.F., Hou S., Das R., Mout R., Rezaee F., Mahmoudi M., Rotello V.M. Regulation of macrophage recognition through the interplay of nanoparticle surface functionality and protein corona. ACS Nano. 2016;10:4421–4430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5696791</ArticleId>
            <ArticleId IdType="pubmed">27040442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tenzer S., Docter D., Rosfa S., Wlodarski A., Kuharev J., Rekik A., Knauer S.K., Bantz C., Nawroth T., Bier C., Sirirattanapan J., Mann W., Treuel L., Zellner R., Maskos M., Schild H., Stauber R.H. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano. 2011;5:7155–7167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21866933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Preissner K. Structure and biological role of vitronectin. Annu. Rev. Cell Biol. 1991;7:275–310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1725600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corbo C., Molinaro R., Parodi A., Furman N.E.T., Salvatore F., Tasciotti E. The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine. 2016;11:81–100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4910943</ArticleId>
            <ArticleId IdType="pubmed">26653875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zensi A., Begley D., Pontikis C., Legros C., Mihoreanu L., Büchel C., Kreuter J. Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain. J. Drug Target. 2010;18:842–848.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20849354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zensi A., Begley D., Pontikis C., Legros C., Mihoreanu L., Wagner S., Büchel C., von Briesen H., Kreuter J. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J. Contr. Release. 2009;137:78–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19285109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 2009;61:428–437.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3683962</ArticleId>
            <ArticleId IdType="pubmed">19376175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chonn A., Semple S.C., Cullis P.R. β2-Glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of “non-self” particles. J. Biol. Chem. 1995;270:25845–25849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7592769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sacchetti C., Motamedchaboki K., Magrini A., Palmieri G., Mattei M., Bernardini S., Rosato N., Bottini N., Bottini M. Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. ACS Nano. 2013;7:1974–1989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23413928</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
